JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on September 26, 2008; DOI: 10.1124/jpet.108.142562


0022-3565/09/3281-213-222$20.00
JPET 328:213-222, 2009
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.108.142562v1
328/1/213    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wuest, M.
Right arrow Articles by Kaumann, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wuest, M.
Right arrow Articles by Kaumann, A. J.

GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

Catecholamines Relax Detrusor through β2-Adrenoceptors in Mouse and β3-Adrenoceptors in Man

Melinda Wuest, Birgit Eichhorn, Marc O. Grimm, Manfred P. Wirth, Ursula Ravens, and Alberto J. Kaumann

Departments of Pharmacology and Toxicology (M.W., B.E., U.R.) and Urology (M.O.G., M.P.W.), Dresden University of Technology, Dresden, Germany; and Department of Physiology, Development, and Neuroscience, University of Cambridge, Cambridge, United Kingdom (A.J.K.)

(-)-Isoproterenol [4-[1-hydroxy-2-[(1-methylethyl)amino]ethyl]-1,2-benzene diol hydrochloride] relaxes murine detrusor through β-adrenoceptors (ARs); however, the β-AR subtypes involved are unknown. β2-ARs have been associated with caveolae, plasma-lemmal scaffolding domains that are absent in caveolin-1 (cav-1) knockout (KO) mice. Here, we studied detrusor responses in the absence and presence of β-AR subtype-selective antagonists in wild-type (WT) and cav-1 KO mice. To inquire whether the murine detrusor model is relevant to man, β-AR subtypes that mediate (-)-isoproterenol-evoked human detrusor relaxation were investigated. In WT mice, (-)-isoproterenol concentration-dependently relaxed the KCl (40 mM)-precontracted detrusor (-logEC50M = 8.04, Emax = 62%). The effects of (-)-isoproterenol were surmountably antagonized by the β2-AR-selective antagonist ICI 118,551 [(±)-1-[2,3-(dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]-2-butanol] (pKB = 9.28) but not affected by the β1-AR-selective antagonist CGP 20712 [1-[2-((3-carbamoyl-4-hydroxy)phenoxy)ethylamino]-3-[4-(1-methyl-4-trifluoromethyl-2-imidazolyl)phenoxy]-2-propanol] and β3-AR-selective L-748,337 [(S)-M-[4-[2-[3-[3-[acetamidomethyl)phenoxy)-2-hydroxypropyl]-amino]-ethyl]-phenylbenzsulfonamide)], suggesting involvement of β2-AR only. The cav-1 KO detrusor displayed significant contractile dysfunction. (-)-Isoproterenol was less potent and efficient in relaxing detrusor from cav-1 KO (-logEC50M, 7.76; Emax = 44%), but ICI 118,551 caused similar antagonism (pKB = 9.15), suggesting that β2-AR function persisted in cav-1 KO. The β3-AR-selective antagonist L-748,337 in the presence of ICI 118,551 and CGP 20712 caused additional blockade of (-)-isoproterenol effects in cav-1 KO, consistent with a β3-AR involvement during relaxation and suppression of this effect in WT. (-)-Isoproterenol relaxed human detrusor muscle precontracted with carbachol (-logEC50M = 6.39, Emax = 52%). However, the effects of (-)-isoproterenol in human detrusor were not blocked by CGP 20712 or ICI 118,551 but antagonized by L-748,337 (pKB = 7.65). We conclude that murine detrusor relaxation occurs via β2-AR, and loss of caveolae does not perturb β2-AR function but unmasks an additional activation of β3-AR. In contrast, detrusor relaxation in man is mediated exclusively via β3-AR.


Received June 23, 2008; accepted September 25, 2008.

Address correspondence to: Melinda Wuest, Department of Pharmacology and Toxicology, Medical Faculty, Dresden University of Technology, Fetscher-strasse 74, 01307 Dresden, Germany. E-mail: melinda.wuest{at}tu-dresden.de







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2009 by the American Society for Pharmacology and Experimental Therapeutics.